Page last updated: 2024-09-04

moxifloxacin and Bacterial Infections, Gram-Positive

moxifloxacin has been researched along with Bacterial Infections, Gram-Positive in 40 studies

Research

Studies (40)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (5.00)	18.2507
2000's	21 (52.50)	29.6817
2010's	16 (40.00)	24.3611
2020's	1 (2.50)	2.80

Authors

Authors	Studies
Black, JA; Hanson, ND; Hong, SG; Hossain, A; Moland, ES; Thomson, KS; Wickman, PA	1
Bradbury, BJ; Buechter, DD; Cheng, J; Deshpande, M; Mushtaq, G; Podos, SD; Pucci, MJ; Thanassi, JA; Thoma, CL; Vigliotti, GA	1
Bryk, A; Kanervo-Nordström, A; Könönen, E; Niemi, P	1
Baudry, PJ; DeCorby, M; Hoban, DJ; Johnson, J; Karlowsky, JA; Lagacé-Wiens, P; Laing, N; McCracken, M; Mulvey, MR; Nichol, KA; Tailor, F; Vashisht, R; Walkty, A; Weshnoweski, B; Wierzbowski, A; Zhanel, GG	1
Jacobus, NV; McDermott, LA; Snydman, DR	1
Beuerman, RW; Chalasani, MLS; Iyer, A; Lakshminarayanan, R; Leng Goh, ET; Lloyd, DG; Madder, A; Mayandi, V; Parmar, A; Prior, SH; Singh, I; Taylor, EJ; Verma, NK	1
Bandow, JE; Hernández, MV; Kalscheuer, R; Meier, D; Muharini, R; Proksch, P; van Geelen, L	1
Chhabria, M; Kudaravalli, P; Lesho, E; Pendela, VS	1
Borgman, CJ	1
Borrego, J; Cobo, F; Navarro-Marí, JM; Rodríguez-Granger, J; Sampedro, A	1
Arvieux, C; Dupont, M; Fily, F; Gicquel, T; Jolivet-Gougeon, A; Polard, E; Verdier, MC	1
Kawasaki, S; Mitani, A; Mito, T; Ohashi, Y; Suzuki, T; Tasaka, Y; Uda, T	1
Aggarwal, H; Ahmed, S; Edwards, P; Gao, H; Kuruvilla, O; Li, Y; Qiao, X; Yee, DC	1
Charlier, C; Lécuyer, H; Lortholary, O; Pilmis, B	1
Gierczyński, R; Jagielski, M; Kochman, M; Piekarska, K; Ławrynowicz-Paciorek, M	1
Alam, MR; Garg, P; Gopinathan, U; Krishnaiah, S; Reddy, AK; Sharma, S	1
Magri, V; Marras, E; Perletti, G; Restelli, A	1
Al-Nawas, B; d'Hoedt, B; Karbach, J; Mouratidou, A	1
Alvey, C; Choo, HW; Cuozzo, C; Damle, B; Kirby, D; Labadie, RR; Riley, S	1
Galvis, V; Rey, JJ; Tello, A; Villareal, D; Wong, CA	1
de Oliveira, LA; de Sousa, LB; do Nascimento, HM; Ecker, DJ; Magalhães, FP; Rosenblatt, MI; Sampath, R; Sannes-Lowery, KA	1
Kawasaki, S; Mito, T; Ohashi, Y; Suzuki, T; Tasaka, Y; Uda, T; Uno, T	1
Asano, K; Betsuyaku, T; Fujiwara, H; Hasegawa, N; Miyata, J; Miyazaki, M; Naoki, K; Ohkusu, K; Sayama, K; Tasaka, S; Yoshida, S	1
Andremont, A; Cavallo, P; Chardon, H; Courvalin, P; Dabernat, H; Drugeon, H; Etienne, J; Goldstein, F; Leclercq, R; Nguyen, J; Rio, Y; Soussy, CJ	1
Braun, J; Dirnagl, U; Halle, E; Megow, D; Meisel, A; Meisel, C; Prass, K; Victorov, I; Volk, HD; Wolf, T	1
Derue, G; Frippiat, F; Meunier, F	1
Choudhri, S; Herrington, J; Malangoni, MA; Pertel, P; Song, J	1
Maguen, E; Morgan, MA	1
Marchese, A; Roveta, S; Schito, AM; Schito, GC	1
Groeneveld, JH; Kuijper, EJ; van Nieuwkoop, C; Visser, LG	1
Amico, LM; Bucci, FA; Evans, RE	1
Allewelt, M; Lode, H; Lorenz, J; Ott, SR; Reimnitz, P	1
Borderie, V; Bourcier, T; Dupas, B; Laroche, L; Maftouhi, AE; Puech, M; Semoun, O	1
Barry, AL; Brown, SD; Fuchs, PC	1
Chartrand, SA; Moland, ES; Pong, A; Sanders, CC; Thomson, KS	1
Amsterdam, D; Hardy, D; Mandell, LA; Rotstein, C	1
Bjarnason, J; Blondeau, JM; Laskowski, R; Stewart, C	1
Barzilai, A; Diamantstein, L; Gruzman, G; Keller, N; Rubinovitch, B; Rubinstein, E; Yoseph, G	1
Fresnadillo Martínez, MJ; Garcia Sánchez, JE	1
Iakovlev, SV; Iakovlev, VP; Polushkina, NR	1

Reviews

2 review(s) available for moxifloxacin and Bacterial Infections, Gram-Positive

Article	Year
Bacillus cereus necrotizing pneumonia in a patient with nephrotic syndrome. Internal medicine (Tokyo, Japan), 2013, Volume: 52, Issue:1 Topics: Adrenal Cortex Hormones; Adult; Anti-Bacterial Agents; Aza Compounds; Bacillus cereus; Biopsy, Needle; Bronchoalveolar Lavage Fluid; Clindamycin; Drug Therapy, Combination; Fluoroquinolones; Follow-Up Studies; Gram-Positive Bacterial Infections; Humans; Immunocompromised Host; Immunohistochemistry; Male; Meropenem; Moxifloxacin; Necrosis; Nephrotic Syndrome; Pneumonia, Bacterial; Quinolines; Radiography, Thoracic; Risk Assessment; Severity of Illness Index; Thienamycins; Tomography, X-Ray Computed; Treatment Outcome	2013
[Moxifloxacin--a novel antimicrobial preparation for treatment of respiratory infections]. Terapevticheskii arkhiv, 2001, Volume: 73, Issue:11 Topics: Anti-Infective Agents; Aza Compounds; Clinical Trials as Topic; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Moxifloxacin; Quinolines; Respiratory Tract Infections	2001

Article

Year

Bacillus cereus necrotizing pneumonia in a patient with nephrotic syndrome.

Internal medicine (Tokyo, Japan), 2013, Volume: 52, Issue:1

Topics: Adrenal Cortex Hormones; Adult; Anti-Bacterial Agents; Aza Compounds; Bacillus cereus; Biopsy, Needle; Bronchoalveolar Lavage Fluid; Clindamycin; Drug Therapy, Combination; Fluoroquinolones; Follow-Up Studies; Gram-Positive Bacterial Infections; Humans; Immunocompromised Host; Immunohistochemistry; Male; Meropenem; Moxifloxacin; Necrosis; Nephrotic Syndrome; Pneumonia, Bacterial; Quinolines; Radiography, Thoracic; Risk Assessment; Severity of Illness Index; Thienamycins; Tomography, X-Ray Computed; Treatment Outcome

2013

[Moxifloxacin--a novel antimicrobial preparation for treatment of respiratory infections].

Terapevticheskii arkhiv, 2001, Volume: 73, Issue:11

Topics: Anti-Infective Agents; Aza Compounds; Clinical Trials as Topic; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Moxifloxacin; Quinolines; Respiratory Tract Infections

2001

Trials

4 trial(s) available for moxifloxacin and Bacterial Infections, Gram-Positive

Article	Year
Lack of an effect of standard and supratherapeutic doses of linezolid on QTc interval prolongation. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:9 Topics: Acetamides; Adult; Anti-Infective Agents; Arrhythmias, Cardiac; Aza Compounds; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Female; Fluoroquinolones; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Moxifloxacin; Oxazolidinones; Quinolines; Young Adult	2011
Randomized controlled trial of moxifloxacin compared with piperacillin-tazobactam and amoxicillin-clavulanate for the treatment of complicated intra-abdominal infections. Annals of surgery, 2006, Volume: 244, Issue:2 Topics: Abdominal Abscess; Administration, Oral; Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Appendicitis; Aza Compounds; Bacterial Infections; Cross Infection; Double-Blind Method; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Intestinal Perforation; Male; Middle Aged; Moxifloxacin; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Quinolines; Safety; Stomach Rupture; Treatment Outcome	2006
Antimicrobial efficacy of prophylactic gatifloxacin 0.3% and moxifloxacin 0.5% in patients undergoing phacoemulsification surgery. Eye & contact lens, 2008, Volume: 34, Issue:1 Topics: Anti-Infective Agents; Antibiotic Prophylaxis; Antitubercular Agents; Aqueous Humor; Aza Compounds; Conjunctiva; Dose-Response Relationship, Drug; Eye Infections, Bacterial; Eyelids; Fluoroquinolones; Gatifloxacin; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Moxifloxacin; Ophthalmic Solutions; Phacoemulsification; Quinolines; Surgical Wound Infection; Treatment Outcome	2008
Moxifloxacin vs ampicillin/sulbactam in aspiration pneumonia and primary lung abscess. Infection, 2008, Volume: 36, Issue:1 Topics: Adult; Ampicillin; Anti-Bacterial Agents; Aza Compounds; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Gram-Negative Facultatively Anaerobic Rods; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Lung Abscess; Male; Moxifloxacin; Pneumonia, Aspiration; Quinolines; Radiography; Sulbactam	2008

Other Studies

34 other study(ies) available for moxifloxacin and Bacterial Infections, Gram-Positive

Article	Year
In vitro studies with DQ-113 and comparison fluoroquinolones to determine propensities to select resistance in gram-positive cocci. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:4 Topics: Drug Resistance, Bacterial; Drug Resistance, Microbial; Fluoroquinolones; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Microbial Sensitivity Tests; Quinolones	2007
In vitro and in vivo antibacterial activities of heteroaryl isothiazolones against resistant gram-positive pathogens. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:4 Topics: Animals; Anti-Infective Agents; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Mice; Microbial Sensitivity Tests; Quinolones; Thiazoles	2007
Antimicrobial susceptibilities of Peptostreptococcus anaerobius and the newly described Peptostreptococcus stomatis isolated from various human sources. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:6 Topics: Anaerobiosis; Anti-Bacterial Agents; Bacteremia; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Peptostreptococcus; Species Specificity	2007
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:4 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Canada; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Population Surveillance	2008
In vitro activities of doripenem, a new broad-spectrum carbapenem, against recently collected clinical anaerobic isolates, with emphasis on the Bacteroides fragilis group. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:12 Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides fragilis; Carbapenems; Doripenem; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests	2008
Design and Syntheses of Highly Potent Teixobactin Analogues against Staphylococcus aureus, Methicillin-Resistant Staphylococcus aureus (MRSA), and Vancomycin-Resistant Enterococci (VRE) in Vitro and in Vivo. Journal of medicinal chemistry, 2018, 03-08, Volume: 61, Issue:5 Topics: Animals; Depsipeptides; Drug Design; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Keratitis; Methicillin-Resistant Staphylococcus aureus; Mice; Staphylococcal Infections; Staphylococcus aureus; Vancomycin Resistance; Vancomycin-Resistant Enterococci	2018
The plant-derived chalcone Xanthoangelol targets the membrane of Gram-positive bacteria. Bioorganic & medicinal chemistry, 2019, 12-01, Volume: 27, Issue:23 Topics: Anti-Bacterial Agents; Cell Line; Chalcone; Fabaceae; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections	2019
Case Report: A Polymicrobial Vision-Threatening Eye Infection Associated with Polysubstance Abuse. The American journal of tropical medicine and hygiene, 2020, Volume: 103, Issue:2 Topics: Administration, Ophthalmic; Adult; Anti-Inflammatory Agents; Antioxidants; Ascorbic Acid; Ceftazidime; Cocaine; Cocaine-Related Disorders; Coinfection; Dopamine Uptake Inhibitors; Doxycycline; Endophthalmitis; Female; Gram-Positive Bacterial Infections; Humans; Keratitis; Kingella; Linezolid; Moxifloxacin; Neisseriaceae Infections; Ophthalmic Solutions; Prednisone; Propionibacterium acnes; Streptococcal Infections; Streptococcus; Substance Abuse, Intravenous; Tobramycin; Vancomycin; Voriconazole	2020
Recurrent conjunctivitis secondary to Gram-positive bacillus, Bacillus thuringiensis. Clinical & experimental optometry, 2018, Volume: 101, Issue:4 Topics: Administration, Ophthalmic; Anti-Bacterial Agents; Bacillus thuringiensis; Conjunctivitis, Bacterial; Dexamethasone; Drug Therapy, Combination; Eye Infections, Bacterial; Glucocorticoids; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Moxifloxacin; Ophthalmic Solutions; Recurrence; Tobramycin	2018
A rare case of pleural infection due to Propionibacterium acnes (Cutibacterium acnes). Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2018, Volume: 31, Issue:2 Topics: Aged; Anti-Bacterial Agents; Fluoroquinolones; Gram-Positive Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Moxifloxacin; Pleural Diseases; Propionibacterium acnes; Pulmonary Disease, Chronic Obstructive; Respiratory Tract Infections	2018
Moxifloxacin-rifampicin combination for the treatment of non-staphylococcal Gram-positive orthopedic implant-related infections. Medecine et maladies infectieuses, 2019, Volume: 49, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Drug Combinations; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Hip Prosthesis; Humans; Male; Middle Aged; Moxifloxacin; Propionibacteriaceae; Prosthesis-Related Infections; Retrospective Studies; Rifampin; Streptococcal Infections; Treatment Outcome	2019
Ocular penetration and efficacy of levofloxacin using different drug-delivery techniques for the prevention of endophthalmitis in rabbit eyes with posterior capsule rupture. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2014, Volume: 30, Issue:4 Topics: Animals; Anti-Bacterial Agents; Aqueous Humor; Drug Delivery Systems; Endophthalmitis; Enterococcus faecalis; Eye Infections, Bacterial; Female; Fluoroquinolones; Gram-Positive Bacterial Infections; Levofloxacin; Moxifloxacin; Ophthalmic Solutions; Posterior Capsular Rupture, Ocular; Rabbits; Vitreous Body	2014
Intraocular penetration of systemic antibiotics in eyes with penetrating ocular injury. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2014, Volume: 30, Issue:10 Topics: Animals; Anti-Bacterial Agents; Ceftazidime; Corneal Injuries; Endophthalmitis; Eye Injuries, Penetrating; Fluoroquinolones; Gram-Positive Bacterial Infections; Intravitreal Injections; Moxifloxacin; Rabbits; Sclera; Vancomycin; Vitreous Body	2014
Enterococcus faecalis-related prostatitis successfully treated with moxifloxacin. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:11 Topics: Anti-Bacterial Agents; Enterococcus faecalis; Fluoroquinolones; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Moxifloxacin; Prostatitis	2015
Novel gyrase mutations and characterization of ciprofloxacin-resistant clinical strains of Enterococcus faecalis isolated in Poland. Polish journal of microbiology, 2008, Volume: 57, Issue:2 Topics: Amino Acid Substitution; Anti-Bacterial Agents; Aza Compounds; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; DNA, Bacterial; Drug Resistance, Bacterial; Enterococcus faecalis; Fluoroquinolones; Genes, Bacterial; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Poland; Polymerase Chain Reaction; Quinolines; Sequence Analysis, DNA	2008
Comparison of in vitro susceptibilities of Gram-positive cocci isolated from ocular infections against the second and fourth generation quinolones at a tertiary eye care centre in South India. Eye (London, England), 2010, Volume: 24, Issue:1 Topics: Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Eye Infections, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Gram-Positive Bacterial Infections; Humans; India; Male; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Quinolones; Retrospective Studies; Staphylococcus; Streptococcus	2010
A severely symptomatic case of anaerobic chronic bacterial prostatitis successfully resolved with moxifloxacin therapy. Anaerobe, 2010, Volume: 16, Issue:3 Topics: Adult; Anti-Bacterial Agents; Aza Compounds; Chronic Disease; Fluoroquinolones; Gram-Positive Bacterial Infections; Humans; Male; Moxifloxacin; Peptostreptococcus; Prostatitis; Quinolines; Treatment Outcome	2010
Antibiotic susceptibility of cocultures in polymicrobial infections such as peri-implantitis or periodontitis: an in vitro model. Journal of periodontology, 2011, Volume: 82, Issue:9 Topics: Acetamides; Actinobacillus Infections; Aggregatibacter actinomycetemcomitans; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Azithromycin; Capnocytophaga; Coculture Techniques; Coinfection; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Linezolid; Metronidazole; Microbial Interactions; Minocycline; Moxifloxacin; Oxazolidinones; Penicillin G; Peptostreptococcus; Peri-Implantitis; Periodontitis; Quinolines; Sulbactam	2011
[In vitro antibiotic susceptibility to fluoroquinolones]. Archivos de la Sociedad Espanola de Oftalmologia, 2012, Volume: 87, Issue:3 Topics: Acanthamoeba Keratitis; Anti-Bacterial Agents; Aza Compounds; Body Fluids; Ciprofloxacin; Colombia; Conjunctivitis, Bacterial; Drug Resistance, Multiple, Bacterial; Eye Infections, Bacterial; Eye Infections, Fungal; Eye Infections, Parasitic; Fluoroquinolones; Gatifloxacin; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Keratitis; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Retrospective Studies	2012
Microbiota evaluation of patients with a Boston type I keratoprosthesis treated with topical 0.5% moxifloxacin and 5% povidone-iodine. Cornea, 2013, Volume: 32, Issue:4 Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents, Local; Antibiotic Prophylaxis; Aza Compounds; Corneal Diseases; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Female; Fluoroquinolones; Gram-Positive Bacterial Infections; Humans; Male; Molecular Diagnostic Techniques; Moxifloxacin; Povidone-Iodine; Prospective Studies; Prostheses and Implants; Quinolines; Staphylococcus aureus	2013
Moxifloxacin as postoperative prophylaxis for Enterococcus faecalis-induced endophthalmitis after cataract surgery in aphakic rabbits. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2013, Volume: 29, Issue:4 Topics: Administration, Ophthalmic; Animals; Anti-Bacterial Agents; Aphakia, Postcataract; Aza Compounds; Disease Models, Animal; Electroretinography; Endophthalmitis; Enterococcus faecalis; Eye Infections, Bacterial; Fluoroquinolones; Gram-Positive Bacterial Infections; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Ophthalmic Solutions; Phacoemulsification; Quinolines; Rabbits; Time Factors	2013
In vitro antibacterial activity of moxifloxacin against hospital isolates: a multicentre study. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2003, Volume: 9, Issue:10 Topics: Anti-Infective Agents; Aza Compounds; Cross Infection; Fluoroquinolones; France; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Moxifloxacin; Quinolines	2003
Preventive antibacterial treatment improves the general medical and neurological outcome in a mouse model of stroke. Stroke, 2004, Volume: 35, Issue:1 Topics: Animals; Antibiotic Prophylaxis; Aza Compounds; Bacterial Infections; Body Weight; Disease Models, Animal; Dose-Response Relationship, Drug; Escherichia coli Infections; Fever; Fluoroquinolones; Gram-Positive Bacterial Infections; Hypothermia; Immune Tolerance; Male; Mice; Mice, Inbred Strains; Moxifloxacin; Opportunistic Infections; Pneumonia, Bacterial; Quinolines; Sepsis; Stroke; Survival Rate; Treatment Outcome	2004
Place of newer quinolones and rifampicin in the treatment of Gram-positive bone and joint infections. The Journal of antimicrobial chemotherapy, 2004, Volume: 54, Issue:6 Topics: Anti-Bacterial Agents; Aza Compounds; Bone Diseases, Infectious; Drug Therapy, Combination; Fluoroquinolones; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Joint Diseases; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Rifampin	2004
A case of vancomycin-resistant enterococcus conjunctivitis and its clinically successful topical treatment. Cornea, 2007, Volume: 26, Issue:2 Topics: Aged; Antitubercular Agents; Aza Compounds; Conjunctivitis, Bacterial; Enterococcus faecalis; Fluoroquinolones; Follow-Up Studies; Gram-Positive Bacterial Infections; Humans; Male; Moxifloxacin; Ophthalmic Solutions; Quinolines; Vancomycin Resistance	2007
Activity of moxifloxacin on biofilms produced in vitro by bacterial pathogens involved in acute exacerbations of chronic bronchitis. International journal of antimicrobial agents, 2007, Volume: 30, Issue:5 Topics: Anti-Bacterial Agents; Aza Compounds; Biofilms; Biomass; Bronchitis, Chronic; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Spectrophotometry	2007
Chronic bacterial prostatitis and relapsing Enterococcus faecalis bacteraemia successfully treated with moxifloxacin. The Journal of infection, 2008, Volume: 56, Issue:2 Topics: Anti-Infective Agents; Aza Compounds; Bacteremia; Chronic Disease; Enterococcus faecalis; Fluoroquinolones; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Moxifloxacin; Prostatitis; Quinolines; Recurrence; Treatment Outcome	2008
Early bacterial keratitis after presbyopic LASIK. Cornea, 2008, Volume: 27, Issue:1 Topics: Administration, Oral; Administration, Topical; Anti-Infective Agents, Local; Aza Compounds; Bacitracin; Cornea; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Gram-Positive Bacterial Infections; Humans; Keratomileusis, Laser In Situ; Microscopy, Confocal; Middle Aged; Moxifloxacin; Pain, Postoperative; Presbyopia; Propionibacterium acnes; Quinolines; Visual Acuity	2008
Antibacterial activity of moxifloxacin (Bay 12-8039) against aerobic clinical isolates, and provisional criteria for disk susceptibility tests. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1999, Volume: 18, Issue:4 Topics: Anti-Infective Agents; Aza Compounds; Bacteria, Aerobic; Ciprofloxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines	1999
Activity of moxifloxacin against pathogens with decreased susceptibility to ciprofloxacin. The Journal of antimicrobial chemotherapy, 1999, Volume: 44, Issue:5 Topics: Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Quinolines; Staphylococcus aureus; Streptococcus pneumoniae	1999
Comparative in vitro activities of ciprofloxacin, gemifloxacin, grepafloxacin, moxifloxacin, ofloxacin, sparfloxacin, trovafloxacin, and other antimicrobial agents against bloodstream isolates of gram-positive cocci. Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:3 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Bacteremia; Ciprofloxacin; Fluoroquinolones; Gemifloxacin; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Piperazines; Quinolines	2000
Comparative in vitro activity of gatifloxacin, grepafloxacin, levofloxacin, moxifloxacin and trovafloxacin against 4151 Gram-negative and Gram-positive organisms. International journal of antimicrobial agents, 2000, Volume: 14, Issue:1 Topics: Anti-Infective Agents; Aza Compounds; Drug Resistance, Microbial; Fluoroquinolones; Gatifloxacin; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Piperazines; Quinolines	2000
The effect of albumin, globulin, pus and dead bacteria in aerobic and anaerobic conditions on the antibacterial activity of moxifloxacin, trovafloxacin and ciprofloxacin against Streptococcus pneumoniae, Staphylococcus aureus and Escherichia coli. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2000, Volume: 6, Issue:12 Topics: Albumins; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Globulins; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Pneumococcal Infections; Quinolines; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae; Suppuration	2000
[Novel antibiotics active against Gram-positive bacteria]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2000, Volume: 13, Issue:4 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Drug Resistance, Microbial; Drug Therapy, Combination; Fluoroquinolones; Gatifloxacin; Gram-Positive Bacterial Infections; Humans; Moxifloxacin; Peptides; Quinolines	2000